Cardiovascular Devices Market
Cardiovascular Devices Market Size, Share & Trends Analysis Report by Technology (Minimally Invasive / Interventional Devices, Implantable Devices, Wearable Cardiac Monitoring Devices), by Product Type (Cardiac Rhythm Management Devices, Interventional Cardiology Devices, Structural Heart Devices, Cardiac Assist Devices, Surgical Devices), by End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Diagnostic Labs), and Forecast Period (2026–2035)
Industry Overview
Cardiovascular devices market was valued at $72.0 billion in 2025 and is expected to reach $131.0 billion by 2035, growing at a CAGR of 6.20% during the forecast period from 2026 to 2035. This market includes a broad range of diagnostic, monitoring, and therapeutic devices used to manage cardiovascular diseases such as coronary artery disease, arrhythmias, and heart failure. The rising global burden of these conditions, driven by aging populations, sedentary lifestyles, and increasing prevalence of risk factors like hypertension and diabetes, is a major factor fueling market growth. In addition, advancements in minimally invasive procedures, implantable cardiac devices, and remote patient monitoring technologies are transforming cardiovascular care by enhancing clinical outcomes and reducing hospital stays. Growing emphasis on early diagnosis and preventive healthcare is also contributing to the increased demand for advanced diagnostic and monitoring solutions.
Recent innovations by key industry players are further accelerating market expansion. In August 2025, GE HealthCare introduced Vivid Pioneer, an advanced AI-powered cardiovascular ultrasound system featuring 2D, 4D, and color flow imaging capabilities, along with AI-driven automation for faster and more accurate diagnosis. The system received both CE Mark and FDA clearance, supporting improved clinical decision-making. Similarly, in January 2025, Abbott Laboratories launched its next-generation Navitor Vision heart valve technology in India for treating severe aortic stenosis. As part of its transcatheter aortic valve implantation (TAVI) system, the device offers a minimally invasive alternative to open-heart surgery, improving valve placement precision and patient outcomes, particularly among high-risk patients. These developments underscore ongoing innovation and strategic expansion efforts by leading companies to strengthen their positions in the cardiovascular devices market.
Market Dynamics
Advanced Imaging Innovations Strengthen Interventional Cardiology Leadership
Interventional cardiology devices continue to dominate the cardiovascular devices market, driven by the rising volume of percutaneous coronary interventions (PCI) performed worldwide. The growing preference for minimally invasive procedures has significantly increased demand for essential devices such as stents, balloons, and catheters, as they enable faster recovery and improved patient outcomes. Continuous technological advancements are further enhancing the precision and efficiency of these procedures. In October 2025, Terumo Corporation announced that its OPUSWAVE Dual Sensor Imaging System and DualView imaging catheter received FDA 510(k) clearance. This innovative system integrates Optical Frequency Domain Imaging (OFDI) and intravascular ultrasound (IVUS) into a single catheter, allowing comprehensive visualization of coronary artery disease during interventions. The advancement supports more accurate decision-making, improves procedural workflow, and strengthens clinical outcomes, reinforcing the segment’s leadership in the market.
Next-Gen Implantable Cardiac Devices Transform Long-Term Heart Care
Implantable devices such as pacemakers, ICDs, and CRT systems play a vital role in managing cardiac arrhythmias and heart failure, supporting long-term disease management. Continuous advancements in battery longevity, device miniaturization, and remote monitoring capabilities are significantly driving their adoption. In February 2026, BIOTRONIK SE & Co. KG introduced its Acticor Sky and Rivacor Sky device family, marking the world’s first CRT-D systems approved for conduction system pacing. These next-generation implantable cardioverter-defibrillators incorporate left bundle branch area pacing (LBBAP) technology, enabling more natural and physiological cardiac stimulation. This innovation enhances treatment precision and improves patient outcomes, particularly for those with complex cardiac conditions. It also reinforces the growing importance of advanced cardiac rhythm management solutions. Overall, such developments are accelerating innovation and strengthening the role of implantable technologies within the cardiovascular devices market.
Market Segmentation
- Based on product type, the market is segmented into cardiac rhythm management devices, interventional cardiology devices, structural heart devices, cardiac assist devices, and surgical devices.
- Based on technology, the market is segmented into minimally invasive/interventional devices, implantable devices, and wearable cardiac monitoring devices.
- Based on end-user, the market is segmented into hospitals, cardiac centers, ambulatory surgical centers, and diagnostic labs.
Wearable Cardiac Monitoring Revolutionizing Preventive Heart Care
Wearable cardiac monitoring devices are experiencing rapid adoption, driven by the growing demand for remote patient monitoring and preventive healthcare solutions. These advanced technologies enable continuous, real-time tracking of heart activity, allowing early detection of cardiac abnormalities and timely clinical intervention. In March 2026, iRhythm Technologies, Inc. presented new clinical evidence at ACC 2026, showcasing the effectiveness of its Zio ambulatory ECG monitoring portfolio in identifying clinically significant arrhythmias across diverse patient populations. The findings emphasized the value of long-term, uninterrupted monitoring in enhancing early diagnosis and improving cardiovascular risk management. Additionally, the company launched iRhythm Academy, a digital education platform aimed at empowering clinicians with knowledge and tools to optimize cardiac care. This development highlights the increasing integration of wearable technology and digital health platforms, significantly advancing patient-centric care and supporting the continued growth of the cardiovascular devices market.
Regional Outlook
The global cardiovascular devices market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America is the leading Region in the market
North America holds a dominant position in the cardiovascular devices market, supported by its advanced healthcare infrastructure and widespread adoption of innovative technologies. The presence of strong reimbursement frameworks further encourages the use of advanced cardiovascular treatments. Additionally, the region experiences a high volume of cardiac procedures, driven by the rising prevalence of heart-related conditions. Early adoption of minimally invasive techniques also contributes to market growth across North America. In January 2026, Boston Scientific announced the approval of its PROMUS coronary stent system in Japan. This next-generation stent, made from cobalt chromium, offers improved strength and enhanced deliverability during procedures. The approval reinforces the company’s interventional cardiology portfolio and supports its expansion in the global cardiovascular devices market. Furthermore, the innovation is expected to improve clinical outcomes for patients suffering from coronary artery disease.
Market Players Outlook
The major companies operating in the global cardiovascular devices market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, and Koninklijke Philips N.V., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In February 2026, Siemens Healthineers AG announced the expansion of its strategic collaboration with Mayo Clinic to enhance patient care through advanced imaging and interventional technologies. The partnership focuses on improving diagnosis and treatment using AI-enabled imaging and innovative minimally invasive solutions. This development supports advancements in diagnostic imaging and interventional technologies, contributing to the broader cardiovascular devices market.
- In August 2025, Medtronic plc received US FDA approval for the expanded Redo-TAVR indication of its Evolut transcatheter aortic valve replacement systems. The approval enables implantation of a new valve inside a failed previously implanted valve, offering a minimally invasive treatment option for high-risk patients. This development strengthens Medtronic’s position in the structural heart devices segment and expands long-term treatment pathways in cardiovascular care.
- In January 2024, Medtronic plc received CE Mark approval for its next-generation Micra AV2 and Micra VR2 leadless pacing systems. These miniaturized pacemakers offer approximately 40% longer battery life and improved programmability compared to previous versions. The devices support minimally invasive implantation and reduced complications, enhancing long-term cardiac rhythm management. This development strengthens innovation in implantable cardiovascular devices within the global market.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global cardiovascular devices market
- Based on the availability of data, information related to new protections and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Cardiovascular Devices Market Sales Analysis – Product Type | Technology| End-User ($ Million)
- Cardiovascular Devices Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach Analytics
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Cardiovascular Devices Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers of Cardiovascular Devices Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Cardiovascular Devices Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Cardiovascular Devices Market Revenue and Share by Manufacturers
- Cardiovascular Devices Type Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Cardinal Health Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Siemens Healthineers AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- GE HealthCare Technologies Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Koninklijke Philips N.V.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Cardinal Health Inc.
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Cardiovascular Devices Market Sales Analysis By Product Type ($ Million)
- Cardiac Rhythm Management Devices
- Interventional Cardiology Devices
- Structural Heart Devices
- Cardiac Assist Devices
- Surgical Devices
- Cardiovascular Devices Market Sales Analysis By Technology ($ Million)
- Minimally Invasive / Interventional Devices
- Implantable Devices
- Wearable Cardiac Monitoring Devices
- Cardiovascular Devices Market Sales Analysis By End User ($ Million)
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Diagnostic Labs
- Regional Analysis
- North American Cardiovascular Devices Market Sales Analysis – Product Type | Technology| End-Users| Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Cardiovascular Devices Market Sales Analysis – Product Type | Technology| End-Users| Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Cardiovascular Devices Market Sales Analysis – Product Type | Technology| End-User| Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the Cardiovascular Devices Market Sales Analysis – Product Type | Technology| End-Users| Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Artivion, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Berlin Heart GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biotronik SE & Co. KG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boston Scientific Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cardinal Health Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Edwards Lifesciences Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fukuda Denshi Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GE HealthCare Technologies Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Getinge AB
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- iRhythm Technologies, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lepu Medical Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- LivaNova PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Meril Life Sciences Pvt. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- MicroPort Scientific Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nihon Kohden Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Schiller AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SynCardia Systems, LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teleflex Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Terumo Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Venus Medtech Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ZOLL Medical Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott
1. Global Cardiovascular Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
2. Global Cardiac Rhythm Management Market Research and Analysis By Region, 2025-2035 ($ Million)
3. Global Interventional Cardiology Market Research and Analysis By Region, 2025-2035 ($ Million)
4. Global Structural Heart Market Research and Analysis By Region, 2025-2035 ($ Million)
5. Global Cardiac Assist Market Research and Analysis By Region, 2025-2035 ($ Million)
6. Global Surgical Market Research and Analysis By Region, 2025-2035 ($ Million)
7. Global Cardiovascular Devices Market Research and Analysis By Technology, 2025-2035 ($ Million)
8. Global Minimally Invasive / Interventional Cardiovascular Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
9. Global Implantable Market Research and Analysis By Region, 2025-2035 ($ Million)
10. Global Wearable Cardiac Monitoring Market Research and Analysis By Region, 2025-2035 ($ Million)
11. Global Cardiovascular Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
12. Global Cardiovascular Devices For Hospitals Market Research and Analysis By Region, 2025-2035 ($ Million)
13. Global Cardiovascular Devices For Cardiac Centers Market Research and Analysis By Region, 2025-2035 ($ Million)
14. Global Cardiovascular Devices For Ambulatory Surgical Centers Market Research and Analysis By Region, 2025-2035 ($ Million)
15. Global Cardiovascular Devices For Diagnostic Labs Market Research and Analysis By Region, 2025-2035 ($ Million)
16. Global Cardiovascular Devices Market Research and Analysis By Region, 2025-2035 ($ Million)
17. North American Cardiovascular Devices Market Research and Analysis By Country, 2025-2035 ($ Million)
18. North American Cardiovascular Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
19. North American Cardiovascular Devices Market Research and Analysis By Technology, 2025-2035 ($ Million)
20. North American Cardiovascular Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
21. European Cardiovascular Devices Market Research and Analysis By Country, 2025-2035 ($ Million)
22. European Cardiovascular Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
23. European Cardiovascular Devices Market Research and Analysis By Technology, 2025-2035 ($ Million)
24. European Cardiovascular Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
25. Asia-Pacific Cardiovascular Devices Market Research and Analysis By Country, 2025-2035 ($ Million)
26. Asia-Pacific Cardiovascular Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
27. Asia-Pacific Cardiovascular Devices Market Research and Analysis By Technology, 2025-2035 ($ Million)
28. Asia-Pacific Cardiovascular Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
29. Rest of the World Cardiovascular Devices Market Research and Analysis By Country, 2025-2035 ($ Million)
30. Rest of the World Cardiovascular Devices Market Research and Analysis By Product Type, 2025-2035 ($ Million)
31. Rest of the World Cardiovascular Devices Market Research and Analysis By Technology, 2025-2035 ($ Million)
32. Rest of the World Cardiovascular Devices Market Research and Analysis By End User, 2025-2035 ($ Million)
1. Global Cardiovascular Devices Market Research and Analysis By Product Type, 2025 Vs 2035 ($ Million)
2. Global Cardiac Rhythm Management Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
3. Global Interventional Cardiology Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
4. Global Structural Heart Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
5. Global Cardiac Assist Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
6. Global Surgical Cardiovascular Devices Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
7. Global Cardiovascular Devices Market Research and Analysis By Technology, 2025 Vs 2035 ($ Million)
8. Global Minimally Invasive / Interventional Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
9. Global Implantable Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
10. Global Wearable Cardiac Monitoring Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
11. Global Cardiovascular Devices Market Research and Analysis By End User, 2025 Vs 2035 ($ Million)
12. Global Cardiovascular Devices For Hospitals Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
13. Global Cardiovascular Devices For Cardiac Centers Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
14. Global Cardiovascular Devices For Ambulatory Surgical Centers Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
15. Global Cardiovascular Devices For Diagnostic Labs Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
16. US Cardiovascular Devices Market Size, 2025-2035 ($ Million)
17. Canada Cardiovascular Devices Market Size, 2025-2035 ($ Million)
18. UK Cardiovascular Devices Market Size, 2025-2035 ($ Million)
19. France Cardiovascular Devices Market Size, 2025-2035 ($ Million)
20. Germany Cardiovascular Devices Market Size, 2025-2035 ($ Million)
21. Italy Cardiovascular Devices Market Size, 2025-2035 ($ Million)
22. Spain Cardiovascular Devices Market Size, 2025-2035 ($ Million)
23. Russia Cardiovascular Devices Market Size, 2025-2035 ($ Million)
24. Rest of Europe Cardiovascular Devices Market Size, 2025-2035 ($ Million)
25. India Cardiovascular Devices Market Size, 2025-2035 ($ Million)
26. China Cardiovascular Devices Market Size, 2025-2035 ($ Million)
27. Japan Cardiovascular Devices Market Size, 2025-2035 ($ Million)
28. South Korea Cardiovascular Devices, 2025-2035 ($ Million)
29. Australia and New Zealand Cardiovascular Devices Market Size, 2025-2035 ($ Million)
30. ASEAN Economies CARDIOVASCULAR DEVICES Market Size, 2025-2035 ($ Million)
31. Rest of Asia-Pacific Cardiovascular Devices Market Size, 2025-2035 ($ Million)
32. Latin America Cardiovascular Devices Market Size, 2025-2035 ($ Million)
33. Middle East and Africa Cardiovascular Devices Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
